XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Class A-1 Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019     76,637,470      
Beginning balance at Dec. 31, 2019 $ (43,010)   $ 8 $ 8,352   $ (51,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Conversion of A-2 common stock to A-1 common stock (in shares)     1,596,636      
Conversion of Class A-2 Common Stock to Class A-1 Common Stock 19,160     19,160    
Stock-based compensation 1,060     1,060    
Net income 48,043         48,043
Ending balance (in shares) at Mar. 31, 2020     78,234,106      
Ending balance at Mar. 31, 2020 25,253   $ 8 28,572   (3,327)
Beginning balance (in shares) at Dec. 31, 2019     76,637,470      
Beginning balance at Dec. 31, 2019 (43,010)   $ 8 8,352   (51,370)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on investments in convertible notes 0          
Net income 8,110          
Ending balance (in shares) at Sep. 30, 2020     92,146,013      
Ending balance at Sep. 30, 2020 122,269   $ 9 165,520   (43,260)
Beginning balance (in shares) at Mar. 31, 2020     78,234,106      
Beginning balance at Mar. 31, 2020 25,253   $ 8 28,572   (3,327)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares)     148,299      
Exercise of common stock options 359     359    
Stock-based compensation 1,327     1,327    
Net income (46,768)         (46,768)
Ending balance (in shares) at Jun. 30, 2020     78,382,405      
Ending balance at Jun. 30, 2020 (19,829)   $ 8 30,258   (50,095)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares)     181,208      
Exercise of common stock options 405     405    
Exercise of warrants (in shares)   510        
Exercise of warrants 4     4    
Exchange of warrants for common stock (in shares)     5,581,890      
Exchange of warrants for common stock 54,471     54,471    
Stock-based compensation 1,668     1,668    
Unrealized gain (loss) on investments in convertible notes 0          
Issuance of common stock (in shares)     8,000,000      
Issuance of common stock 78,715 $ 1   78,714    
Net income 6,835         6,835
Ending balance (in shares) at Sep. 30, 2020     92,146,013      
Ending balance at Sep. 30, 2020 122,269   $ 9 165,520   (43,260)
Beginning balance (in shares) at Dec. 31, 2020     93,379,508      
Beginning balance at Dec. 31, 2020 127,871   $ 9 179,549 $ 93 (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 1,593     1,593    
Unrealized gain (loss) on investments in convertible notes 469       469  
Net income 1,501         1,501
Ending balance (in shares) at Mar. 31, 2021     93,379,508      
Ending balance at Mar. 31, 2021 131,434   $ 9 181,142 562 (50,279)
Beginning balance (in shares) at Dec. 31, 2020     93,379,508      
Beginning balance at Dec. 31, 2020 127,871   $ 9 179,549 93 (51,780)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Unrealized gain (loss) on investments in convertible notes 5,358          
Net income 24,753          
Ending balance (in shares) at Sep. 30, 2021     94,042,341      
Ending balance at Sep. 30, 2021 164,144   $ 9 185,711 5,451 (27,027)
Beginning balance (in shares) at Mar. 31, 2021     93,379,508      
Beginning balance at Mar. 31, 2021 131,434   $ 9 181,142 562 (50,279)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares)     281,245      
Exercise of common stock options 685     685    
Stock-based compensation 2,148     2,148    
Unrealized gain (loss) on investments in convertible notes 5,204       5,204  
Net income 12,445         12,445
Ending balance (in shares) at Jun. 30, 2021     93,660,753      
Ending balance at Jun. 30, 2021 151,916   $ 9 183,975 5,766 (37,834)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of common stock options (in shares)     381,588      
Exercise of common stock options 770     770    
Stock-based compensation 966     966    
Unrealized gain (loss) on investments in convertible notes (315)       (315)  
Net income 10,807         10,807
Ending balance (in shares) at Sep. 30, 2021     94,042,341      
Ending balance at Sep. 30, 2021 $ 164,144   $ 9 $ 185,711 $ 5,451 $ (27,027)